164 related articles for article (PubMed ID: 14680975)
1. Variants in the PPARgamma gene affect fatty acid and glycerol metabolism in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Vermeulen VM; de Bruin TW
Mol Genet Metab; 2003 Nov; 80(3):296-301. PubMed ID: 14680975
[TBL] [Abstract][Full Text] [Related]
2. High frequency of a retinoid X receptor gamma gene variant in familial combined hyperlipidemia that associates with atherogenic dyslipidemia.
Nohara A; Kawashiri MA; Claudel T; Mizuno M; Tsuchida M; Takata M; Katsuda S; Miwa K; Inazu A; Kuipers F; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):923-8. PubMed ID: 17272748
[TBL] [Abstract][Full Text] [Related]
3. C3, hormone-sensitive lipase, and peroxisome proliferator-activated receptor gamma expression in adipose tissue of familial combined hyperlipidemia patients.
Ylitalo K; Nuotio I; Viikari J; Auwerx J; Vidal H; Taskinen MR
Metabolism; 2002 May; 51(5):664-70. PubMed ID: 11979403
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in adipose triglyceride lipase influence lipid levels in familial combined hyperlipidemia.
Nanni L; Quagliarini F; Megiorni F; Montali A; Minicocci I; Campagna F; Pizzuti A; Arca M
Atherosclerosis; 2010 Nov; 213(1):206-11. PubMed ID: 20832801
[TBL] [Abstract][Full Text] [Related]
5. Impaired activation of adipocyte lipolysis in familial combined hyperlipidemia.
Reynisdottir S; Eriksson M; Angelin B; Arner P
J Clin Invest; 1995 May; 95(5):2161-9. PubMed ID: 7738184
[TBL] [Abstract][Full Text] [Related]
6. Identification of the PPARA locus on chromosome 22q13.3 as a modifier gene in familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; Flavell DM; de Bruin TW
Mol Genet Metab; 2002 Dec; 77(4):274-81. PubMed ID: 12468272
[TBL] [Abstract][Full Text] [Related]
7. Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.
Castro Cabezas M; de Bruin TW; de Valk HW; Shoulders CC; Jansen H; Willem Erkelens D
J Clin Invest; 1993 Jul; 92(1):160-8. PubMed ID: 8100834
[TBL] [Abstract][Full Text] [Related]
8. Evidence of insulin resistant lipid metabolism in adipose tissue in familial combined hyperlipidemia, but not type 2 diabetes mellitus.
van der Kallen CJ; Voors-Pette C; Bouwman FG; Keizer HA; Lu JY; van de Hulst RR; Bianchi R; Janssen MJ; Keulen ET; Boeckx WD; Rotter JI; de Bruin TW
Atherosclerosis; 2002 Oct; 164(2):337-46. PubMed ID: 12204806
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of CD36/FAT in preadipocytes in familial combined hyperlipidemia.
Meex SJ; van der Kallen CJ; van Greevenbroek MM; Eurlings PM; El Hasnaoui M; Evelo CT; Lindsey PJ; Luiken JJ; Glatz JF; de Bruin TW
FASEB J; 2005 Dec; 19(14):2063-5. PubMed ID: 16219805
[TBL] [Abstract][Full Text] [Related]
10. The Pro12A1a substitution in the peroxisome proliferator activated receptor gamma 2 is associated with an insulin-sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia.
Pihlajamäki J; Miettinen R; Valve R; Karjalainen L; Mykkänen L; Kuusisto J; Deeb S; Auwerx J; Laakso M
Atherosclerosis; 2000 Aug; 151(2):567-74. PubMed ID: 10924736
[TBL] [Abstract][Full Text] [Related]
11. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1).
Pajukanta P; Lilja HE; Sinsheimer JS; Cantor RM; Lusis AJ; Gentile M; Duan XJ; Soro-Paavonen A; Naukkarinen J; Saarela J; Laakso M; Ehnholm C; Taskinen MR; Peltonen L
Nat Genet; 2004 Apr; 36(4):371-6. PubMed ID: 14991056
[TBL] [Abstract][Full Text] [Related]
12. Unraveling the complex genetics of familial combined hyperlipidemia.
Suviolahti E; Lilja HE; Pajukanta P
Ann Med; 2006; 38(5):337-51. PubMed ID: 16938803
[TBL] [Abstract][Full Text] [Related]
13. Gender differences in postprandial ketone bodies in normolipidemic subjects and in untreated patients with familial combined hyperlipidemia.
Halkes CJ; van Dijk H; Verseyden C; de Jaegere PP; Plokker HW; Meijssen S; Erkelens DW; Cabezas MC
Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1875-80. PubMed ID: 12933534
[TBL] [Abstract][Full Text] [Related]
14. Genetic dissection of familial combined hyperlipidemia.
Eurlings PM; van der Kallen CJ; Geurts JM; van Greevenbroek MM; de Bruin TW
Mol Genet Metab; 2001; 74(1-2):98-104. PubMed ID: 11592807
[TBL] [Abstract][Full Text] [Related]
15. Contribution of chromosome 1q21-q23 to familial combined hyperlipidemia in Mexican families.
Huertas-Vázquez A; del Rincón JP; Canizales-Quinteros S; Riba L; Vega-Hernández G; Ramírez-Jiménez S; Aurón-Gómez M; Gómez-Pérez FJ; Aguilar-Salinas CA; Tusié-Luna MT
Ann Hum Genet; 2004 Sep; 68(Pt 5):419-27. PubMed ID: 15469419
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of blood-derived cell lines in familial combined hyperlipidemia.
Morello F; de Bruin TW; Rotter JI; Pratt RE; van der Kallen CJ; Hladik GA; Dzau VJ; Liew CC; Chen YD
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2149-54. PubMed ID: 15388524
[TBL] [Abstract][Full Text] [Related]
17. Novel drugs in familial combined hyperlipidemia: lessons from type 2 diabetes mellitus.
Brouwers MC; de Graaf J; van Greevenbroek MM; Schaper N; Stehouwer CD; Stalenhoef AF
Curr Opin Lipidol; 2010 Dec; 21(6):530-8. PubMed ID: 20739883
[TBL] [Abstract][Full Text] [Related]
18. Abdominal obesity and expression of familial combined hyperlipidemia.
van der Kallen CJ; Voors-Pette C; de Bruin TW
Obes Res; 2004 Dec; 12(12):2054-61. PubMed ID: 15687407
[TBL] [Abstract][Full Text] [Related]
19. Codon 54 polymorphism of the human intestinal fatty acid binding protein 2 gene is associated with dyslipidemias but not with insulin resistance in patients with familial combined hyperlipidemia.
Pihlajamäki J; Rissanen J; Heikkinen S; Karjalainen L; Laakso M
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1039-44. PubMed ID: 9194752
[TBL] [Abstract][Full Text] [Related]
20. Plasma PAI-1 levels are independently related to fatty liver and hypertriglyceridemia in familial combined hyperlipidemia, involvement of apolipoprotein E.
Brouwers MC; Govers-Riemslag J; Schalkwijk CG; van Greevenbroek MM; van der Kallen CJ; Bekers O; van Dieijen-Visser MP; Ten Oever J; Bilderbeek-Beckers MA; de Bruin TW; Ten Cate H; Stehouwer CD
Thromb Res; 2008; 122(4):466-72. PubMed ID: 18262228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
